Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding study of Antiadipositum X 112 T in obesity
2009-010116-15Phase 2Completed
- Sponsor
- RIEMSER
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cathine in obesity (4 arms), sponsored by RIEMSER. Primary endpoint: Weight reduction after 12 weeks. Started Feb 2010; status: completed.
02
Drugs
cathine
03
Conditions
obesity
Beyond the preview
Go deeper on 2009-010116-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010116-15.